Tim DraperFounder and Managing Partne, Draper Associate · I back the ideas that look crazy first

What if reversing aging didn’t take 10 years - or a billion dollars? 😱

7 Feb 2026 · 1 min

Watch on YouTube

0:55

Two researchers plan to launch five gene therapies for aging by repurposing drugs already proven safe for other diseases, cutting development costs from $1 billion to $200,000. They're using a regulatory framework that lets them sell treatments once safety is shown, skipping the usual efficacy trials.

Chapters

We are launching 5 gene therapies and first combo treatment for muscle growth, cognitive enhancement, and more. We've reduced the average cost of bringing drug to market from $1 billion to $200,000.
How do you reduce it? Are you going through Prospera's FDA or are you trying something else?
Yes, through local IRB. So we are concentrating currently on the low-hanging fruits, the therapies that already have some safety and efficiency profile but they are used for disease. And we bring it here and repurpose them for longevity purposes, to slow down and reverse aging.
Within PROSPRA, you can start to commercialize once you clear the safety hurdle.
Yeah.
Not necessarily efficacy hurdle.
Yeah, exactly.
Which in the US is different.